Dr. Miver Erem Tokuş
NeurosurgeryVerified
- 24+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Brain Surgery
Removal of meningioma
What removal of meningioma involves, including surgical craniotomy and stereotactic radiosurgery, the Simpson grading of resection, and evidence for recurrence prevention. Compare approximate costs in Turkey with the UK, US, and Germany, understand the hospital stay and rehabilitation timeline, review neurological risks, and learn how to evaluate specialised neurosurgical teams before travelling for skull base or cranial surgery.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Brain Surgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Removal of Meningioma
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
What is removal of meningioma and when is surgery necessary?
The removal of meningioma is a specialised neurosurgical intervention designed to excise a tumour arising from the meninges—the protective membranous layers surrounding the brain and spinal cord. Meningiomas originate from arachnoid cap cells and account for approximately one-third of all primary intracranial neoplasms. Most are classified as histologically benign (World Health Organization Grade I), but because they develop within the rigid confines of the skull, their physical growth can compress adjacent brain parenchyma, cranial nerves, and major vascular channels. When patients develop persistent headaches, seizures, visual disturbances, or focal neurological deficits, surgical intervention is often indicated to relieve mass effect and obtain definitive histological diagnosis. For international patients seeking cranial care, these procedures form a central discipline among neurosurgery treatments in Turkey.
The primary surgical objective is total excision of the tumour mass together with its dural base attachment, known as gross total resection, whenever this can be achieved safely without damaging critical neural structures. In cases where the tumour encases vital cranial nerves or adheres to major venous sinuses, neurosurgeons intentionally leave a tiny residual cuff to preserve neurological function, often combining surgery with targeted radiation. Understanding the surgical process, realistic prognosis, international pricing, and recovery requirements helps patients and families navigate treatment decisions objectively.
How does surgical removal of meningioma work step by step?
A standard removal of meningioma proceeds through coordinated phases in a specialised neurosurgical operating theatre. First, the patient is placed under general anaesthesia with continuous arterial line and neurological monitoring. High-resolution navigation systems correlate pre-operative MRI and CT scans with the patient's exact cranial position, allowing the surgeon to plan the minimal bone opening necessary to expose the tumour while safeguarding speech, motor, or visual pathways.
The neurosurgeon creates a scalp incision and performs a craniotomy, temporarily elevating a small section of skull bone flap directly over the lesion. Upon opening the dura mater, micro-instruments and surgical operating microscopes are deployed. Intraoperative ultrasound or neuronavigation verifies the tumour margins. Neurosurgeons frequently use an ultrasonic aspirator (CUSA) to fragment and debulk the firm tumour tissue internally, reducing tension before gently dissecting the tumour capsule away from the surrounding brain tissue and blood vessels.
Once the tumour is excised, the dural attachment site is either coagulated or removed and reconstructed with a synthetic or autologous dural graft (duraplasty) to prevent cerebrospinal fluid leakage. Haemostasis is confirmed under direct magnification. Finally, the cranial bone flap is repositioned and secured using low-profile titanium plates and micro-screws, and the scalp is closed meticulously in multiple layers.
Does surgical excision work, and what determines recurrence?
Surgical excision remains the definitive primary treatment for symptomatic meningiomas. Long-term outcomes are closely tied to the extent of resection, traditionally categorised by the neurosurgical Simpson grading system. Simpson Grade I (complete removal of the tumour, dural attachment, and any abnormal bone) offers the lowest recurrence rate over a ten-year period. However, achieving Grade I is not always biologically feasible or clinically safe, particularly when tumours occupy complex skull base corridors, encircle the internal carotid artery, or invade the cavernous sinus.
When tumours are partially resected (Simpson Grades III to V) to prevent disabling stroke or nerve palsies, secondary control strategies such as stereotactic radiosurgery or planned surveillance are deployed. The biological behaviour of the tissue also dictates durability: World Health Organization (WHO) Grade I tumours exhibit slow growth and low recurrence rates, whereas atypical (Grade II) and anaplastic or malignant (Grade III) variants carry higher rates of progression and typically require adjuvant post-operative radiotherapy. Clinical evidence confirms that microsurgical debulking reliably eliminates mass effect, reverses progressive neurological deficits in most patients, and provides tissue for accurate molecular and histopathological grading.
Removal of meningioma cost in Turkey compared with the UK, US and Germany
The cost of brain tumour surgery reflects intensive hospital resources, including advanced operating microscopes, intraoperative neuro-navigation, neuro-monitoring consumables, and mandatory stays in an intensive care unit (ICU). The figures below present approximate ranges for comprehensive hospital admissions, including pre-operative evaluation, surgical fees, anaesthesia, hospitalisation, and initial post-operative imaging. They do not constitute specific hospital quotations.
| Country | Approximate cost range |
|---|---|
| Turkey | €8,000 – €22,000 |
| United Kingdom | €18,000 – €45,000 |
| United States | €40,000 – €110,000 |
| Germany | €19,000 – €48,000 |
Several clinical variables influence the final removal of meningioma price and overall removal of meningioma cost. Tumour location is the primary determinant: a superficial convexity meningioma requires a straightforward craniotomy, whereas a complex petroclival, sphenoid wing, or foramen magnum lesion demands prolonged skull base micro-dissection, extended theatre time, and multiple intraoperative specialists. The duration of stay in the neuro-intensive care unit, requirements for post-operative rehabilitation, and whether secondary procedures (such as cranial reconstruction or adjuvant radiotherapy) are necessary also adjust the total expenditure. An all-inclusive medical travel package typically covers pre-operative blood panels and imaging, neurosurgical and anaesthetic fees, standard ICU and ward accommodation, routine prescription medicines, airport transfers, and multilingual patient coordination.
Craniotomy, radiosurgery or transnasal resection: comparing surgical techniques
Not every meningioma requires an open cranial operation, and surgical approaches vary depending on anatomical depth and relation to critical neurovascular structures. Open craniotomy remains the gold standard for tumours exerting acute mass effect or those located across the cerebral convexity, falx cerebri, or tentorium. For specific midline lesions, alternative corridors allow surgeons to avoid extensive brain retraction altogether.
Selected tumours positioned at the tuberculum sellae, planum sphenoidale, or olfactory groove can be accessed through the nostrils using high-definition endoscopes; patients considering this corridor can explore our comprehensive guide to transnasal resection of tumor. In contrast, small tumours located deep in the skull base without urgent mass effect, as well as residual tumour cuffs left after surgery, are often managed with stereotactic radiosurgery (such as Gamma Knife or CyberKnife). Radiosurgery does not excise the mass immediately but arrests cellular growth by delivering focused radiation beams.
| Approach | Best suited to | Typical limits |
|---|---|---|
| Open craniotomy (microsurgery) | Accessible convexity, falcine, and tentorial tumours causing mass effect | Requires bone window, variable brain retraction, and longer hospital recovery |
| Transnasal endoscopic resection | Midline anterior skull base and sellar region meningiomas | Anatomically restricted; requires specific surgical corridors and careful dural sealing |
| Stereotactic radiosurgery (SRS) | Small (<3 cm), residual, or high-risk skull base tumours without brainstem shift | Does not immediately debulk tissue volume; radiation oedema can occur |
| Active surveillance (wait-and-scan) | Incidental, small, asymptomatic, calcified tumours in stable patients | Tumour remains in situ; mandates periodic high-resolution MRI scans |
When deciding between open approaches and endoscopic routes such as transnasal resection of tumor, neurosurgical teams evaluate tumour size, vascular encasement, sinus invasion, and the patient’s overall neurological baseline.
Who is an appropriate candidate for meningioma resection?
Determining candidacy for surgical resection involves balancing the natural history of the tumour against the risks of intracranial intervention. Clear indications for surgery include documented tumour enlargement on serial MRI scans, significant peritumoural oedema (brain swelling), refractory seizures, progressive motor or sensory deficits, and impending visual loss caused by optic pathway compression.
Conversely, surgery is often deferred in patients with small, asymptomatic, densely calcified tumours discovered incidentally on brain imaging performed for unrelated reasons (such as head trauma or routine headaches). In these cases, serial observation via annual MRI is standard medical practice, particularly for elderly individuals or patients with severe cardiopulmonary co-morbidities. Patients presenting with poor medical fitness, severe uncorrectable coagulopathies, or tumours whose total removal would predictably result in catastrophic neurological deficits are evaluated for non-invasive stereotactic irradiation or palliative medical management instead.
What are realistic before and after outcomes following meningioma surgery?
Patients evaluating cranial surgery frequently ask what "before and after" outcomes look like in clinical reality. Unlike cosmetic surgery, post-operative success in neurosurgery is measured on cross-sectional neuro-imaging and functional neurological scorecards rather than external aesthetic changes. Before surgery, MRI scans display a distinct, contrast-enhancing mass creating brain distortion, midline shift, and surrounding white-matter swelling. After successful intervention, post-operative scans demonstrate resolution of mass effect, restoration of normal ventricular alignment, and absence of abnormal contrast enhancement at the resection cavity.
From a functional standpoint, realistic recovery depends on the duration and severity of symptoms before the operation. Headaches and cognitive slowing driven by elevated intracranial pressure often improve within days or weeks once mass effect is relieved. However, long-standing visual deficits or motor weakness caused by prolonged cranial nerve compression may recover slowly over 6 to 12 months, or may remain partially permanent if neural tissue has suffered irreversible ischemic injury. External photographs show a healed scalp incision hidden within the hairline, with temporary regional hair clipping that regrows naturally within three to six months.
Hospital stay, travel timeline and recovery after meningioma surgery
Planning for removal of meningioma in Turkey requires an organised clinical journey lasting approximately 12 to 16 days in the host city. Upon arrival, the patient undergoes baseline laboratory testing, neuro-ophthalmological assessment if indicated, and thin-slice volumetric MRI neuronavigation planning. The surgery typically lasts between three and six hours depending on complexity.
Following the operation, the patient spends one to two nights in a dedicated neuro-intensive care unit for continuous haemodynamic and neurological monitoring, followed by four to six days in a private hospital inpatient room. During ward recovery, physical and occupational therapists initiate gentle mobilisation. After hospital discharge, patients remain in local accommodation for several days to attend wound dressing checks, suture or clip removal, and a final follow-up MRI scan. Understanding removal of meningioma recovery helps manage expectations: neurosurgeons assess brain re-expansion and ensure the absence of subdural collections or trapped air (pneumocephalus) before certifying the patient as medically fit to fly. Returning to sedentary office work generally takes 6 to 8 weeks, while full physical recovery and strenuous sports typically require 3 to 6 months.
Surgical risks, potential complications and safety standards
Craniotomy for tumour resection is a major surgical procedure carrying defined risks. Professional organisations, including the European Association of Neurosurgical Societies (EANS) and the British Association of Spine and Neurosurgical Surgeons, emphasize that complication rates vary based on tumour size, skull base involvement, and patient age. Recognised surgical risks include:
- Cerebrospinal fluid (CSF) leakage: Occurs when the dural repair fails to create a watertight seal, potentially necessitating lumbar drainage or secondary surgical revision.
- Intracranial haemorrhage or venous thrombosis: Bleeding within the surgical bed or thrombosis of adjacent dural venous sinuses can cause secondary ischaemia or increased pressure.
- Infection: Meningitis, wound infection, or bone flap osteomyelitis requiring intravenous antibiotics and occasional temporary flap removal.
- Neurological deficits: Weakness, numbness, speech difficulties, or cranial nerve palsies (such as facial weakness or double vision), which may be transient or permanent.
- Post-operative seizures: Irritation of the cerebral cortex during dissection can trigger seizures, prompting the routine prophylactic use of anti-epileptic medications during the peri-operative period.
- General medical complications: Deep vein thrombosis, pulmonary embolism, pneumonia, or reactions to general anaesthetic agents.
Hospitals operating under international accreditation mitigate these hazards through routine use of continuous intraoperative neuro-physiological monitoring (IONM), advanced neuro-navigation, and micro-vascular Doppler sonography to preserve critical vessels.
How to select a neurosurgical team in Turkey and critical red flags
Choosing a surgical team for brain surgery requires meticulous verification of clinical qualifications, institutional infrastructure, and emergency capabilities. When researching removal of meningioma Turkey providers, confirm that the operating surgeon is a specialist in cranial neurosurgery with documented fellowship experience in neuro-oncology or skull base surgery. The hospital must feature an advanced surgical suite with continuous neuro-navigation, high-magnification operating microscopes, an on-site blood bank, and a dedicated tertiary neuro-intensive care unit staffed round-the-clock by neuro-intensivists.
Be alert to critical red flags when assessing clinics. Caution is warranted if a facilitator provides an immediate quote without requesting high-resolution DICOM format MRI scans, promises complete 100% tumour removal regardless of anatomical proximity to vital vessels, or downplays the necessity of an ICU stay. Reliable clinics discuss potential neurological risks transparently and outline clear emergency protocols. You can review how it works when coordinating international neurosurgical admissions, and explore our full range of neurosurgery treatments in Turkey. Submitting your recent cranial scans for a free quote initiates a direct case review by certified neurosurgical specialists.
Questions to ask your neurosurgical team
- What is the precise anatomical location and estimated Simpson grade of resection you expect to achieve?
- Will continuous intraoperative neuro-monitoring (IONM) and computer-guided neuronavigation be utilised during my procedure?
- How many cranial or skull base meningioma resections does the lead neurosurgeon perform each year?
- What specific neurological deficits or nerve risks are associated with my tumour’s location?
- How many nights will I spend in the dedicated neuro-intensive care unit, and what is your protocol if complications arise?
- What are the criteria and timeline for post-operative MRI imaging before I am cleared to fly home?
Hospitals with Neurosurgery in Turkey
Frequently asked questions
Removal of meningioma is a neurosurgical operation to excise a tumour arising from the meninges, the protective coverings of the brain and spinal cord. Using micro-instruments, high-magnification microscopes, and computer-guided neuronavigation, neurosurgeons remove the tumour mass and its dural attachment to eliminate compression on adjacent brain tissue, cranial nerves, and blood vessels.
Most meningiomas are non-cancerous World Health Organization Grade I tumours. When a surgeon achieves complete excision of the tumour and its dural base—known as a Simpson Grade I resection—the cure rate is high, and recurrence over ten years is uncommon. If tiny tumour fragments must be left near critical nerves, recurrence risk increases, requiring periodic monitoring or targeted radiosurgery.
Removal of meningioma cost in Turkey generally ranges between €8,000 and €22,000, compared with €18,000 to €45,000 in the UK and higher in the US. The price varies based on tumour location, surgical complexity, required neuro-monitoring equipment, and days spent in the neuro-intensive care unit. Hospitals provide confirmed, itemised quotes following detailed MRI review.
Before surgery, MRI and CT scans show a distinct tumour mass distorting brain parenchyma, causing midline shift or surrounding oedema. After successful surgery, imaging reveals complete decompression of neural pathways, resolution of mass effect, and an empty resection cavity without pathological contrast enhancement. Functional recovery of pre-existing neurological symptoms depends on whether permanent nerve damage occurred prior to treatment.
Initial hospital recovery involves one to two days in intensive care and four to six days in a ward. Most patients return to light domestic activities within three to four weeks, resuming desk work after six to eight weeks. Full physical recovery and clearance for vigorous activity typically takes three to six months as cognitive fatigue subsides and brain tissue adapts.
The brain tissue itself does not possess pain receptors, and the operation is conducted under general anaesthesia. Following surgery, patients experience local scalp soreness, neck stiffness, and tension-type headaches around the incision site. This discomfort is actively managed with scheduled intravenous analgesics in the hospital and tapering oral pain medications during early home recovery.
For benign tumours that undergo complete resection, results are long-lasting and often permanent. However, because meningiomas can occasionally recur years later, patients undergo scheduled MRI surveillance scans at regular intervals—typically annually for the first five years, then biennially. Atypical or malignant variants carry a higher tendency to regrow, often requiring adjuvant radiation therapy to maintain local disease control.
While all brain surgery involves significant clinical risk, modern microsurgical techniques, computer neuronavigation, and continuous intraoperative neuro-monitoring have made meningioma excision predictable and safe. Potential risks include cerebrospinal fluid leaks, infection, neurological deficits, bleeding, and seizures. Safety is maximized by having operations performed in high-volume neurosurgical centres with dedicated neuro-intensive care units and experienced skull base teams.
Craniotomy is preferred for large tumours, those causing acute mass effect, or lesions threatening vision, because it immediately debulks the mass. Stereotactic radiosurgery is typically preferred for small, surgically inaccessible skull base tumours, residual tumour remnants, or patients unable to tolerate general anaesthesia. A multidisciplinary neuro-oncology board evaluates imaging to recommend the most suitable modality.
Patients travelling to Turkey should plan for a total stay of 12 to 16 days. This duration accommodates pre-operative neuro-imaging, surgical scheduling, five to seven days of total inpatient hospitalisation, suture removal, and a mandatory post-operative MRI scan. The neurosurgeon must confirm adequate healing and absence of trapped cranial air before certifying the patient fit to fly.
Patient stories